title: Prognostic value of unrecognised myocardial infarction detected by late gadolinium-enhanced MRI in diabetic patients with normal global and regional left ventricular systolic function.
abstract: OBJECTIVE
  To determine whether the detection of unrecognised myocardial infarction (MI) using late gadolinium-enhanced (LGE)-magnetic resonance imaging (MRI) can provide prognostic information in diabetic patients with normal ECG as well as normal global and regional left ventricular (LV) function.
  
  
  METHODS
  From 449 diabetic patients who had complete cine- and LGE-MRI, 321 patients with histories of CAD, ischaemic ECG changes and abnormal cine MRI findings (LV ejection fraction <50 % or presence of regional wall motion abnormality) were excluded. The presence and extent of LGE were determined in the remaining 128 patients. Follow-up information was obtained for the occurrence of major adverse cardiovascular events (MACE) defined as cardiac death, acute MI, heart failure, unstable angina and significant ventricular arrhythmias in 120 patients.
  
  
  RESULTS
  Of 120 patients, 18 (15 %) had LGE. During follow-up (median, 27 months), six patients with LGE (33.3 %) and four patients without LGE (3.9 %) experienced MACE, resulting in an annualised event rate of 7.7 % and 0.9 %, respectively (log-rank P <0.001). The presence of LGE was associated with an eight-fold increased hazard for MACE (HR, 8.84; P = 0.001).
  
  
  CONCLUSIONS
  LGE-MRI can detect unrecognised MI and may improve the risk stratification of diabetic patients with no CAD history, normal ECG and normal LV systolic function.
  
  
  CONCLUSIONS
  • Late gadolinium-enhanced magnetic resonance imaging (LGE-MRI) can identify subtle myocardial abnormalities. • LGE-MRI can detect myocardial infarction missed by ECG and cine-MRI. • Unrecognised MI detected by LGE-MRI was associated with adverse cardiac events. • LGE-MRI helps clinicians to assess diabetic patients with unrecognised MI.
authors.affiliation: Department of Radiology, Mie University Hospital, 2-174 Edobashi, Tsu, Mie, 514-8507, Japan.
authors.forename: Yeonyee E
authors.initials: YE
authors.lastname: Yoon
authors.forename: Kakuya
authors.initials: K
authors.lastname: Kitagawa
authors.forename: Shingo
authors.initials: S
authors.lastname: Kato
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Nakajima
authors.forename: Tairo
authors.initials: T
authors.lastname: Kurita
authors.forename: Kaoru
authors.initials: K
authors.lastname: Dohi
authors.forename: Masaaki
authors.initials: M
authors.lastname: Ito
authors.forename: Hajime
authors.initials: H
authors.lastname: Sakuma
mesh_terms: D000368:Aged; D003287:Contrast Media; D048909:Diabetes Complications / Q000175:diagnosis / Q000473:pathology; D003920:Diabetes Mellitus / Q000473:pathology*; D004562:Electrocardiography; D005260:Female; D005682:Gadolinium; D006801:Humans; D008279:Magnetic Resonance Imaging; D019028:Magnetic Resonance Imaging, Cine; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis* / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D011379:Prognosis; D012306:Risk; D013599:Systole / Q000502:physiology; D016277:Ventricular Function, Left / Q000502:physiology*
chemical_list: D003287:Contrast Media; D005682:Gadolinium
references.citation: JAMA. 2009 Apr 15;301(15):1547-55
references.pmid: 19366774
references.citation: Am J Cardiol. 2006 Oct 15;98(8):1045-6
references.pmid: 17027568
references.citation: Arch Intern Med. 1989 Jul;149(7):1528-32
references.pmid: 2742427
references.citation: Circulation. 2006 Jun 13;113(23):2733-43
references.pmid: 16754804
references.citation: J Am Coll Cardiol. 1997 Mar 15;29(4):862-79
references.pmid: 9091535
references.citation: JAMA. 2003 May 21;289(19):2560-72
references.pmid: 12748199
references.citation: Circulation. 2007 Jul 10;116(2):143-50
references.pmid: 17576870
references.citation: Circulation. 2009 Nov 24;120(21):2069-76
references.pmid: 19901193
references.citation: Lancet. 1985 Jun 15;1(8442):1360-2
references.pmid: 2861314
references.citation: Lancet. 2004 Aug 21-27;364(9435):685-96
references.pmid: 15325833
references.citation: Int J Cardiovasc Imaging. 2010 Feb;26 Suppl 1:123-31
references.pmid: 20049536
references.citation: Am J Cardiol. 2000 Feb 15;85(4):411-5
references.pmid: 10728942
references.citation: Diabetes Care. 2004 Aug;27(8):1954-61
references.pmid: 15277423
references.citation: Circulation. 2002 Dec 17;106(25):3143-421
references.pmid: 12485966
references.citation: Diabetes Care. 2004 May;27(5):1047-53
references.pmid: 15111519
references.citation: Am J Cardiol. 2000 Nov 1;86(9):897-902
references.pmid: 11053695
references.citation: AJR Am J Roentgenol. 2009 Jul;193(1):W25-32
references.pmid: 19542379
references.citation: Radiology. 2012 Mar;262(3):807-15
references.pmid: 22274838
references.citation: Eur Heart J. 2010 Jan;31(1):92-9
references.pmid: 19797259
references.citation: Am J Cardiol. 1996 Jun 1;77(14):1149-54
references.pmid: 8651086
references.citation: Circulation. 2008 Sep 2;118(10):1011-20
references.pmid: 18725488
references.citation: N Engl J Med. 1984 Nov 1;311(18):1144-7
references.pmid: 6482932
references.citation: Nephron. 1976;16(1):31-41
references.pmid: 1244564
references.citation: Diabetes Care. 2003 Jan;26 Suppl 1:S5-20
references.pmid: 12502614
references.citation: Clin Cardiol. 1998 Oct;21(10):725-30
references.pmid: 9789692
references.citation: Radiology. 2002 Jun;223(3):789-97
references.pmid: 12034951
references.citation: J Cardiovasc Magn Reson. 2005;7(4):639-47
references.pmid: 16136853
references.citation: Eur Radiol. 2004 Dec;14(12):2155-62
references.pmid: 15351901
references.citation: Circulation. 2001 Jun 12;103(23):2780-3
references.pmid: 11401931
references.citation: J Hypertens. 2008 Nov;26(11):2103-11
references.pmid: 18854748
references.citation: N Engl J Med. 1998 Sep 24;339(13):861-7
references.pmid: 9744969
references.citation: Eur Radiol. 2003 Mar;13(3):498-506
references.pmid: 12594551